4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0000950170-24-000874
Chief Financial Officer sold 5,182 shares at $3.66 ($18,966)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dulac Edward J III Chief Financial Officer | 2024-01-02 | Sale 10b5-1 | −5,182 | $3.66 | $18,966 | 112,803 | D |
| Open-market sales · 5,182 sh · avg $3.66 · $18,966 | |||||||
Loading xslF345X05/ownership.xml…